A Defect of Amphiregulin Release Predicted Longer Survival Independently of YAP Expression in Patients with Pleural Mesothelioma in the IFCT-0701 MAPS Phase 3 Trial

  • Etude concernée: MAPS
  • Auteurs / Authors: Maille E, Levallet J, Dubois F, Antoine M, Danel C, Creveuil C, Mazieres J, Margery J, Greillier L, Gounant V, Moro-Sibilot D, Molinier O, Léna H, Monnet I, Bergot E, Langlais A, Morin F, Sherpereel A, Zalcman G, Levallet G
  • Journal / Conference: International Journal of Cancer
  • Année / Year: 2022
  • PMID: 35262190
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/35262190/